Published in Br J Pharmacol on February 01, 2003
Nitric oxide and peroxynitrite in health and disease. Physiol Rev (2007) 15.49
Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol (2004) 5.29
Ryanodine receptors: structure, expression, molecular details, and function in calcium release. Cold Spring Harb Perspect Biol (2010) 2.46
Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo. Proc Natl Acad Sci U S A (2004) 2.33
Heat shock proteins as emerging therapeutic targets. Br J Pharmacol (2005) 2.25
Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol (2008) 2.15
Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo. Free Radic Biol Med (2006) 1.99
Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am J Physiol Heart Circ Physiol (2009) 1.89
Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev (2007) 1.86
Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics. Cardiovasc Res (2007) 1.69
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. Br J Pharmacol (2007) 1.65
Protein S-nitrosylation and cardioprotection. Circ Res (2010) 1.63
Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci (2005) 1.53
Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling. Br J Pharmacol (2007) 1.52
Mitochondrial nitroalkene formation and mild uncoupling in ischaemic preconditioning: implications for cardioprotection. Cardiovasc Res (2008) 1.41
Potential therapeutic benefits of strategies directed to mitochondria. Antioxid Redox Signal (2010) 1.40
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death. Free Radic Biol Med (2011) 1.24
CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes. Cardiovasc Res (2009) 1.22
CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model. Br J Pharmacol (2010) 1.18
Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury. Front Physiol (2011) 1.14
Proteomic analysis of protein tyrosine nitration after ischemia reperfusion injury: mitochondria as the major target. Biochim Biophys Acta (2008) 1.14
Thioredoxin reduces post-ischemic myocardial apoptosis by reducing oxidative/nitrative stress. Br J Pharmacol (2006) 1.11
Role of heat shock protein 90 and endothelial nitric oxide synthase during early anesthetic and ischemic preconditioning. Anesthesiology (2009) 1.08
The paradigm of postconditioning to protect the heart. J Cell Mol Med (2007) 1.07
Mitochondrial fission in endothelial cells after simulated ischemia/reperfusion: role of nitric oxide and reactive oxygen species. Free Radic Biol Med (2011) 1.06
Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy. J Cell Mol Med (2008) 1.05
A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury. Br J Pharmacol (2012) 1.04
Peroxynitrite: just an oxidative/nitrosative stressor or a physiological regulator as well? Br J Pharmacol (2006) 1.02
Endothelial cell respiration is affected by the oxygen tension during shear exposure: role of mitochondrial peroxynitrite. Am J Physiol Cell Physiol (2008) 1.02
The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning. Br J Pharmacol (2014) 1.01
Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol (2010) 1.00
Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo. Cardiovasc Res (2010) 0.98
Redox modulation of HMGB1-related signaling. Antioxid Redox Signal (2013) 0.94
Nitrite in organ protection. Br J Pharmacol (2014) 0.93
Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte. Br J Pharmacol (2007) 0.92
Ca2+-mediated ascorbate release from coronary artery endothelial cells. Br J Pharmacol (2006) 0.92
Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction. J Cell Mol Med (2010) 0.91
Formation of hydrogen peroxide and reduction of peroxynitrite via dismutation of superoxide at reperfusion enhances myocardial blood flow and oxygen consumption in postischemic mouse heart. J Pharmacol Exp Ther (2008) 0.91
Emergent role of gasotransmitters in ischemia-reperfusion injury. Med Gas Res (2011) 0.89
Protein tyrosine nitration and thiol oxidation by peroxynitrite-strategies to prevent these oxidative modifications. Int J Mol Sci (2013) 0.89
Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors. Br J Pharmacol (2012) 0.88
Neonatal asphyxia induces the nitration of cardiac myosin light chain 2 that is associated with cardiac systolic dysfunction. Shock (2010) 0.88
Submaximal PPARγ activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders. Br J Pharmacol (2012) 0.88
Decreased tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning. Am J Physiol Heart Circ Physiol (2011) 0.87
Intravenous adenosine protects the myocardium primarily by activation of a neurogenic pathway. Br J Pharmacol (2005) 0.87
Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation. J Transplant (2012) 0.86
Nitric oxide in the cardiovascular system: a simple molecule with complex actions. Cardiovasc J Afr (2009) 0.85
Hyperlipidaemia induced by a high-cholesterol diet leads to the deterioration of guanosine-3',5'-cyclic monophosphate/protein kinase G-dependent cardioprotection in rats. Br J Pharmacol (2009) 0.85
Peroxynitrite decreases arrhythmias induced by ischaemia reperfusion in anaesthetized dogs, without involving mitochondrial KATP channels. Br J Pharmacol (2008) 0.84
Delivery of Nox2-NADPH oxidase siRNA with polyketal nanoparticles for improving cardiac function following myocardial infarction. Biomaterials (2013) 0.84
3',4'-Dihydroxyflavonol reduces infarct size and injury associated with myocardial ischaemia and reperfusion in sheep. Br J Pharmacol (2004) 0.84
Preemptive conditioning of the swine heart by H11 kinase/Hsp22 provides cardiac protection through inducible nitric oxide synthase. Am J Physiol Heart Circ Physiol (2011) 0.84
Cardiac capsaicin-sensitive sensory nerves regulate myocardial relaxation via S-nitrosylation of SERCA: role of peroxynitrite. Br J Pharmacol (2007) 0.84
Effects of ischemic postconditioning on the hemodynamic parameters and heart nitric oxide levels of hypothyroid rats. Arq Bras Cardiol (2014) 0.84
Both cGMP and peroxynitrite mediate chronic interleukin-6-induced negative inotropy in adult rat ventricular myocytes. J Physiol (2005) 0.83
Dietary red palm oil supplementation reduces myocardial infarct size in an isolated perfused rat heart model. Lipids Health Dis (2010) 0.82
Cardiac NO signalling in the metabolic syndrome. Br J Pharmacol (2014) 0.82
Wine polyphenols induce hypotension, and decrease cardiac reactivity and infarct size in rats: involvement of nitric oxide. Br J Pharmacol (2004) 0.82
Post-ischemic early acidosis in cardiac postconditioning modifies the activity of antioxidant enzymes, reduces nitration, and favors protein S-nitrosylation. Pflugers Arch (2011) 0.82
Adrenomedullin acts via nitric oxide and peroxynitrite to protect against myocardial ischaemia-induced arrhythmias in anaesthetized rats. Br J Pharmacol (2006) 0.81
Fluid Mechanical Forces and Endothelial Mitochondria: A Bioengineering Perspective. Cell Mol Bioeng (2014) 0.81
Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivo. PLoS One (2013) 0.81
Redox signalling and cardioprotection: translatability and mechanism. Br J Pharmacol (2015) 0.81
Kallidin-like peptide mediates the cardioprotective effect of the ACE inhibitor captopril against ischaemic reperfusion injury of rat heart. Br J Pharmacol (2006) 0.81
Ketamine-induced gastroprotection during endotoxemia: role of heme-oxygenase-1. Dig Dis Sci (2006) 0.81
Hyperoxia and transforming growth factor β1 signaling in the post-ischemic mouse heart. Life Sci (2013) 0.80
Oxidative stress as a common mediator for apoptosis induced-cardiac damage in diabetic rats. Open Cardiovasc Med J (2008) 0.80
Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.80
Cardioprotective Effect of Licochalcone D against Myocardial Ischemia/Reperfusion Injury in Langendorff-Perfused Rat Hearts. PLoS One (2015) 0.79
Green tea polyphenol extract attenuates ischemia/reperfusion injury of the gut. Naunyn Schmiedebergs Arch Pharmacol (2005) 0.79
Oridonin induces apoptosis and autophagy in murine fibrosarcoma L929 cells partly via NO-ERK-p53 positive-feedback loop signaling pathway. Acta Pharmacol Sin (2012) 0.79
The effects of ischemic postconditioning on myocardial function and nitric oxide metabolites following ischemia-reperfusion in hyperthyroid rats. Korean J Physiol Pharmacol (2014) 0.79
The role of nitric oxide, superoxide and peroxynitrite in the anti-arrhythmic effects of preconditioning and peroxynitrite infusion in anaesthetized dogs. Br J Pharmacol (2010) 0.78
The role of arginase and rho kinase in cardioprotection from remote ischemic perconditioning in non-diabetic and diabetic rat in vivo. PLoS One (2014) 0.78
The in vitro effects of superoxide, some commercially available antioxidants and red palm oil on sperm motility. Asian J Androl (2009) 0.78
Specific Mechanisms Underlying Right Heart Failure: The Missing Upregulation of Superoxide Dismutase-2 and Its Decisive Role in Antioxidative Defense. Antioxid Redox Signal (2015) 0.78
Superoxide dismutase as a novel macromolecular nitric oxide carrier: preparation and characterization. Int J Mol Sci (2012) 0.78
Measurement of NO in biological samples. Br J Pharmacol (2014) 0.78
The effects of N-acetylcysteine on cisplatin-induced cardiotoxicity on isolated rat hearts after short-term global ischemia. Toxicol Rep (2015) 0.77
Intracellular regulation of matrix metalloproteinase-2 activity: new strategies in treatment and protection of heart subjected to oxidative stress. Scientifica (Cairo) (2013) 0.77
Thioredoxin reductase was nitrated in the aging heart after myocardial ischemia/reperfusion. Rejuvenation Res (2013) 0.77
Peroxynitrite: in vivo cardioprotectant or arrhythmogen? Br J Pharmacol (2008) 0.76
Vitamin C: new role of the old vitamin in the cardiovascular system? Br J Pharmacol (2006) 0.76
Interaction between connexin 43 and nitric oxide synthase in mice heart mitochondria. J Cell Mol Med (2015) 0.76
Oxygen mediates vascular smooth muscle relaxation in hypoxia. PLoS One (2013) 0.76
Propofol administration to the fetal-maternal unit reduces cardiac oxidative stress in preterm lambs subjected to prenatal asphyxia and cardiac arrest. Pediatr Res (2016) 0.76
High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats. Braz J Med Biol Res (2013) 0.75
Functional Impact of Ryanodine Receptor Oxidation on Intracellular Calcium Regulation in the Heart. Rev Physiol Biochem Pharmacol (2016) 0.75
Nitric oxide fails to confer endogenous antiarrhythmic cardioprotection in the primate heart in vitro. Br J Pharmacol (2007) 0.75
Targeting TRAF3IP2 by genetic and interventional approaches inhibits ischemia/reperfusion-induced myocardial injury and adverse remodeling. J Biol Chem (2017) 0.75
An isolated working heart system for large animal models. J Vis Exp (2014) 0.75
The valosin-containing protein is a novel mediator of mitochondrial respiration and cell survival in the heart in vivo. Sci Rep (2017) 0.75
Nitric oxide treatments as adjuncts to reperfusion in acute myocardial infarction: a systematic review of experimental and clinical studies. Basic Res Cardiol (2016) 0.75
Impaired cardiac ischemic tolerance in spontaneously hypertensive rats is attenuated by adaptation to chronic and acute stress. Exp Clin Cardiol (2011) 0.75
Exogenous Nitric Oxide Protects Human Embryonic Stem Cell-Derived Cardiomyocytes against Ischemia/Reperfusion Injury. Oxid Med Cell Longev (2016) 0.75
Protection by the NO-Donor SNAP and BNP against Hypoxia/Reoxygenation in Rat Engineered Heart Tissue. PLoS One (2015) 0.75
GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease. Cell Signal (2017) 0.75
Fenofibrate attenuates impaired ischemic preconditioning-mediated cardioprotection in the fructose-fed hypertriglyceridemic rat heart. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.75
High-throughput screening identifies microRNAs that target Nox2 and improve function after acute myocardial infarction. Am J Physiol Heart Circ Physiol (2017) 0.75
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation (1986) 19.82
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol (1996) 13.14
Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A (1991) 8.04
The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J (1973) 7.01
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet (1992) 5.36
The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol (1987) 4.88
Enzyme-independent formation of nitric oxide in biological tissues. Nat Med (1995) 4.28
Myocardial reperfusion: a double-edged sword? J Clin Invest (1985) 4.12
The late phase of preconditioning. Circ Res (2000) 3.71
Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem (1994) 3.64
Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat Rev Mol Cell Biol (2002) 3.38
The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci U S A (1999) 3.32
Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res (2000) 3.19
Molecular and cellular mechanisms of myocardial stunning. Physiol Rev (1999) 3.16
Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol (2001) 2.82
Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res (2000) 2.80
Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation (1998) 2.79
Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem (1996) 2.33
NG-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res (1993) 2.30
The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res (1999) 2.27
Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation (2002) 2.25
Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim Biophys Acta (2001) 2.21
The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol (1998) 2.19
Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation (2002) 2.14
Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am J Physiol (1999) 2.13
Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation (2000) 2.01
Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation (1996) 1.84
Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase. FASEB J (1995) 1.84
Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ Res (1999) 1.81
Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem (2001) 1.80
The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock (1996) 1.78
Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res (1995) 1.75
Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway. Br J Pharmacol (1992) 1.71
Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction. Circ Res (2001) 1.70
Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res (2001) 1.61
Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci U S A (1994) 1.53
Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest (1996) 1.52
Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res (1997) 1.47
A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ Res (2001) 1.40
Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. J Pharmacol Exp Ther (2000) 1.40
Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ Res (1998) 1.39
Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide. Arch Biochem Biophys (1997) 1.38
Signal transduction of ischemic preconditioning. Cardiovasc Res (2001) 1.38
Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol (2000) 1.35
Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice. Circulation (1999) 1.34
Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res (1997) 1.33
Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc Res (2002) 1.30
Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc Natl Acad Sci U S A (1994) 1.29
The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation (1992) 1.28
Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest (1997) 1.24
Nitric oxide regulation of tissue free radical injury. Chem Res Toxicol (1996) 1.24
Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circ Res (1996) 1.22
Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther (1992) 1.22
Extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite. Crit Care Med (1997) 1.21
Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury. Hypertension (1999) 1.20
Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic Biol Med (1998) 1.19
Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol (1997) 1.15
Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning. Br J Pharmacol (1999) 1.12
p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation. Cardiovasc Res (2002) 1.12
Contribution of NO to ischemia-reperfusion injury in the saline-perfused heart: a study in endothelial NO synthase knockout mice. J Mol Cell Cardiol (1999) 1.10
Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol (2000) 1.10
Role of nitric oxide and its interaction with superoxide in the suppression of cardiac muscle mitochondrial respiration. Involvement in response to hypoxia/reoxygenation. Circulation (1996) 1.10
Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation (1995) 1.10
Involvement of nitric oxide and nitrosothiols in relaxation of pulmonary arteries to peroxynitrite. Am J Physiol (1994) 1.08
The effect of nitric oxide generators on ischemia reperfusion injury and histamine release in isolated perfused guinea-pig heart. Agents Actions (1991) 1.07
Peroxynitrite impairs cardiac contractile function by decreasing cardiac efficiency. Am J Physiol (1997) 1.06
Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischaemic preconditioning in the rabbit. Cardiovasc Res (1994) 1.05
Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury. Cardiovasc Res (1995) 1.05
The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on. Basic Res Cardiol (2002) 1.05
Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats. Circulation (1997) 1.04
Peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified soluble guanylyl cyclase. Dependence on glutathione and possible role of S-nitrosation. J Biol Chem (1995) 1.02
Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice. Circulation (2000) 1.02
Late preconditioning elicited by activation of adenosine A(3) receptor in heart: role of NF- kappa B, iNOS and mitochondrial K(ATP) channel. J Mol Cell Cardiol (2002) 1.01
Lactate and PO2 modulate superoxide anion production in bovine cardiac myocytes: potential role of NADH oxidase. Circulation (1997) 1.00
Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. J Mol Cell Cardiol (1997) 1.00
Basal release of nitric oxide augments the Frank-Starling response in the isolated heart. Circulation (1997) 0.99
Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts. Circulation (1999) 0.99
Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation (1997) 0.97
Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase. Mol Med (2001) 0.97
Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon? Trends Pharmacol Sci (1998) 0.96
The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res (1999) 0.96
Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rat hearts. Am J Physiol (1999) 0.96
Delayed preconditioning of myocardium: current perspectives. Basic Res Cardiol (2001) 0.96
Peroxynitrite: toxic or protective in the heart? Circ Res (2001) 0.96
Glutathione protects against myocardial ischemia-reperfusion injury by detoxifying peroxynitrite. J Mol Cell Cardiol (2000) 0.95
Mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury. Am J Physiol (1998) 0.94
Physiological effects of peroxynitrite: potential products of the environment. Circ Res (2000) 0.93
Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit. Cardiovasc Res (1995) 0.93
Increase in endogenous antioxidant enzymes protects hearts against reperfusion injury. Am J Physiol (1993) 0.92
Ischemic preconditioning: exploring the paradox. Prog Cardiovasc Dis (1998) 0.92
Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo. J Clin Invest (1998) 0.92
Inhibition of nitric oxide synthesis does not affect ischemic preconditioning in isolated perfused rat hearts. Am J Physiol (1995) 0.91
Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: role of nitric oxide. Br J Pharmacol (1995) 0.91
Apoptosis induction by nitric oxide in adult cardiomyocytes via cGMP-signaling and its impairment after simulated ischemia. Cardiovasc Res (2000) 0.91
Role of nitric oxide in the regulation of myocardial function. Prog Cardiovasc Dis (1995) 0.90
Repeated cardiac pacing extends the time during which canine hearts are protected against ischaemia-induced arrhythmias: role of nitric oxide. J Mol Cell Cardiol (1999) 0.90
Inhibition of endogenous nitric oxide synthase potentiates ischemia-reperfusion-induced myocardial apoptosis via a caspase-3 dependent pathway. Cardiovasc Res (2000) 0.90
Adenosine A(1) receptor mediates late preconditioning via activation of PKC-delta signaling pathway. Am J Physiol Heart Circ Physiol (2002) 0.89
Effect of duration of ischaemia on reduction of myocardial infarct size by inhibition of neutrophil accumulation using an anti-CD18 monoclonal antibody. Br J Pharmacol (1994) 0.89
Enhancing the quality of life of dementia caregivers from different ethnic or racial groups: a randomized, controlled trial. Ann Intern Med (2006) 4.13
Long-term mortality and quality of life after prolonged mechanical ventilation. Crit Care Med (2004) 3.36
Patients' recollections of stressful experiences while receiving prolonged mechanical ventilation in an intensive care unit. Crit Care Med (2002) 2.91
A motivational theory of life-span development. Psychol Rev (2010) 2.89
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70
Effect of multicomponent interventions on caregiver burden and depression: the REACH multisite initiative at 6-month follow-up. Psychol Aging (2003) 2.70
Review and meta-analysis of couple-oriented interventions for chronic illness. Ann Behav Med (2010) 2.47
The Resources for Enhancing Alzheimer's Caregiver Health (REACH): project design and baseline characteristics. Psychol Aging (2003) 2.36
Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation (2002) 2.25
The course of functional decline in older people with persistently elevated depressive symptoms: longitudinal findings from the Cardiovascular Health Study. J Am Geriatr Soc (2005) 2.20
Is it beneficial to involve a family member? A meta-analysis of psychosocial interventions for chronic illness. Health Psychol (2004) 2.14
Adaptive self-regulation of unattainable goals: goal disengagement, goal reengagement, and subjective well-being. Pers Soc Psychol Bull (2003) 2.13
Isolated heart perfusion according to Langendorff---still viable in the new millennium. J Pharmacol Toxicol Methods (2006) 2.06
Trust in the health care system and the use of preventive health services by older black and white adults. Am J Public Health (2008) 2.04
Family caregivers' strains: comparative analysis of cancer caregiving with dementia, diabetes, and frail elderly caregiving. J Aging Health (2008) 1.94
Prevalence and outcomes of caregiving after prolonged (> or =48 hours) mechanical ventilation in the ICU. Chest (2004) 1.91
Risk factors for potentially harmful informal caregiver behavior. J Am Geriatr Soc (2005) 1.81
Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury. Circulation (2010) 1.80
Caregiving behavior is associated with decreased mortality risk. Psychol Sci (2009) 1.76
Caregiver-specific outcomes in antidementia clinical drug trials: a systematic review and meta-analysis. J Am Geriatr Soc (2005) 1.75
Effect of an in-home occupational and physical therapy intervention on reducing mortality in functionally vulnerable older people: preliminary findings. J Am Geriatr Soc (2006) 1.71
Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J Clin Invest (2002) 1.70
Preparedness for the death of a loved one and mental health in bereaved caregivers of patients with dementia: findings from the REACH study. J Palliat Med (2006) 1.69
Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro. FASEB J (2004) 1.69
Patient-specific, time-varying predictors of post-ICU informal caregiver burden: the caregiver outcomes after ICU discharge project. Chest (2009) 1.69
Benefit-finding in the cancer caregiving experience. Psychosom Med (2007) 1.67
Informal caregiver burden among survivors of prolonged mechanical ventilation. Am J Respir Crit Care Med (2006) 1.64
The association of race and socioeconomic status with cardiovascular disease indicators among older adults in the health, aging, and body composition study. J Gerontol B Psychol Sci Soc Sci (2002) 1.58
Interpersonal effects of suffering in older adult caregiving relationships. Psychol Aging (2009) 1.56
Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation (2005) 1.56
Depression and distress predict time to cardiovascular disease in dementia caregivers. Health Psychol (2007) 1.55
Transitions in spousal caregiving. Gerontologist (2003) 1.54
Caregiving at the end of life. J Palliat Med (2006) 1.54
Clinical research and the stages of dying. Omega (Westport) (1974) 1.53
Using a new taxonomy to combine the uncombinable: integrating results across diverse interventions. Psychol Aging (2003) 1.53
Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci (2005) 1.53
The Life Engagement Test: assessing purpose in life. J Behav Med (2006) 1.50
Financial exploitation and psychological mistreatment among older adults: differences between African Americans and non-African Americans in a population-based survey. Gerontologist (2010) 1.49
Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions. Health Psychol (2003) 1.48
Patterns of depressive symptoms in caregivers of mechanically ventilated critically ill adults from intensive care unit admission to 2 months postintensive care unit discharge: a pilot study. Crit Care Med (2012) 1.45
Preparing family caregivers for death and bereavement. Insights from caregivers of terminally ill patients. J Pain Symptom Manage (2008) 1.42
The prognostic significance of inspiratory capacity in pulmonary arterial hypertension. Respiration (2014) 1.41
An evidence-based medicine elective course to improve student performance in advanced pharmacy practice experiences. Am J Pharm Educ (2011) 1.41
Postresuscitation administration of doxycycline preserves cardiac contractile function in hypoxia-reoxygenation injury of newborn piglets*. Crit Care Med (2014) 1.40
Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix. Cardiovasc Res (2009) 1.39
Prevalence and correlates of anxiety symptoms in well-functioning older adults: findings from the health aging and body composition study. J Am Geriatr Soc (2003) 1.38
Preparing caregivers for the death of a loved one: a theoretical framework and suggestions for future research. J Palliat Med (2006) 1.35
Positive and negative religious coping and well-being in women with breast cancer. J Palliat Med (2009) 1.34
Development of the risk appraisal measure: a brief screen to identify risk areas and guide interventions for dementia caregivers. J Am Geriatr Soc (2009) 1.33
Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med (2006) 1.33
A methodology for describing and decomposing complex psychosocial and behavioral interventions. Psychol Aging (2003) 1.32
Older spouses' perceptions of partners' chronic arthritis pain: implications for spousal responses, support provision, and caregiving experiences. Psychol Aging (2006) 1.32
Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc Res (2002) 1.30
Positive aspects of caregiving and adaptation to bereavement. Psychol Aging (2004) 1.28
Activation and modulation of 72kDa matrix metalloproteinase-2 by peroxynitrite and glutathione. Biochem Pharmacol (2008) 1.28
Health stresses and depressive symptomatology in the elderly: the importance of health engagement control strategies. Health Psychol (2002) 1.27
Hospital costs in patients receiving prolonged mechanical ventilation: does age have an impact? Crit Care Med (2003) 1.26
Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res (2002) 1.23
Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats. Am J Physiol Heart Circ Physiol (2002) 1.23
Regulation of matrix metalloproteinase-2 (MMP-2) activity by phosphorylation. FASEB J (2007) 1.23
Association of enjoyable leisure activities with psychological and physical well-being. Psychosom Med (2009) 1.22
Interventions to enhance physical and psychological functioning among younger women who are ending nonhormonal adjuvant treatment for early-stage breast cancer. J Clin Oncol (2005) 1.18
Guiding research in family care: a new approach to oncology caregiving. Psychooncology (2008) 1.16
Depressive symptoms in older African-American and white adults with functional difficulties: the role of control strategies. J Am Geriatr Soc (2007) 1.14
Matrix metalloproteinase-7 and ADAM-12 (a disintegrin and metalloproteinase-12) define a signaling axis in agonist-induced hypertension and cardiac hypertrophy. Circulation (2009) 1.13
Making sense of mild cognitive impairment: a qualitative exploration of the patient's experience. Gerontologist (2006) 1.12
Socioeconomic position and incident mobility impairment in the Cardiovascular Health Study. BMC Geriatr (2007) 1.10
Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury. J Mol Cell Cardiol (2007) 1.09
Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction. Cardiovasc Res (2003) 1.08
Obstructive sleep apnea, oxidative stress and cardiovascular disease: lessons from animal studies. Oxid Med Cell Longev (2013) 1.07
Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosom Med (2010) 1.07
Data and safety monitoring in social behavioral intervention trials: the REACH II experience. Clin Trials (2006) 1.07
Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition. J Pharmacol Exp Ther (2005) 1.07
Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection. J Infect Dis (2008) 1.07
Religious beliefs and practices are associated with better mental health in family caregivers of patients with dementia: findings from the REACH study. Am J Geriatr Psychiatry (2006) 1.07
Verbal communication among Alzheimer's disease patients, their caregivers, and primary care physicians during primary care office visits. Patient Educ Couns (2009) 1.05
Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart. Eur Heart J (2004) 1.05
Spouses' cardiovascular reactivity to their partners' suffering. J Gerontol B Psychol Sci Soc Sci (2010) 1.05
Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion. Basic Res Cardiol (2008) 1.04
Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial [correction of myoctardial] ischemia-reperfusion injury. Circulation (2003) 1.04
Generalized anxiety disorder in late life: lifetime course and comorbidity with major depressive disorder. Am J Geriatr Psychiatry (2005) 1.03
Physical health problems, depressive mood, and cortisol secretion in old age: buffer effects of health engagement control strategies. Health Psychol (2007) 1.02
Finding the best ways to help: opportunities and challenges of intervention research on aging. Gerontologist (2003) 1.02
Peroxynitrite in myocardial ischemia-reperfusion injury. Heart Fail Rev (2002) 1.01
Acute lung injury is reduced in fat-1 mice endogenously synthesizing n-3 fatty acids. Am J Respir Crit Care Med (2009) 1.01
Improving well-being in caregivers of terminally ill patients. Making the case for patient suffering as a focus for intervention research. J Pain Symptom Manage (2007) 1.00
Matrix metalloproteinase inhibitor properties of tetracyclines: therapeutic potential in cardiovascular diseases. Pharmacol Res (2011) 1.00
What questions do family caregivers want to discuss with health care providers in order to prepare for the death of a loved one? An ethnographic study of caregivers of patients at end of life. J Palliat Med (2008) 1.00
Lower quality of life among women with chronic pelvic pain after pelvic inflammatory disease. Obstet Gynecol (2003) 1.00
Concurrent and long-term predictors of older adults' use of community-based long-term care services: the Caregiver Health Effects Study. J Aging Health (2004) 1.00
Does who you marry matter for your health? Influence of patients' and spouses' personality on their partners' psychological well-being following coronary artery bypass surgery. J Pers Soc Psychol (2006) 1.00
Role of social support in predicting caregiver burden. Arch Phys Med Rehabil (2012) 0.98
Racial differences in self-rated health at similar levels of physical functioning: an examination of health pessimism in the health, aging, and body composition study. J Gerontol B Psychol Sci Soc Sci (2009) 0.98
Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9. Mol Cell Biochem (2003) 0.97
Group-based trajectory modeling of caregiver psychological distress over time. Ann Behav Med (2012) 0.97
Executive functions and cognitive subprocesses in patients with obstructive sleep apnoea. J Sleep Res (2008) 0.97
Concordance of race or ethnicity of interventionists and caregivers of dementia patients: relationship to attrition and treatment outcomes in the REACH study. Gerontologist (2006) 0.96
Concordance of four methods of disability assessment using performance in the home as the criterion method. Arthritis Rheum (2003) 0.96
MMP-2 and MMP-9 and their tissue inhibitors in the plasma of preterm and term neonates. Pediatr Res (2004) 0.96
E-care: a telecommunications technology intervention for family caregivers of dementia patients. Am J Geriatr Psychiatry (2007) 0.95